Exogenous Ketones Lower Blood Glucose Level in Rested and Exercised Rodent Models

Diseases involving inflammation and oxidative stress can be exacerbated by high blood glucose levels. Due to tight metabolic regulation, safely reducing blood glucose can prove difficult. The ketogenic diet (KD) reduces absolute glucose and insulin, while increasing fatty acid oxidation, ketogenesis, and circulating levels of β-hydroxybutyrate (βHB), acetoacetate (AcAc), and acetone. Compliance to KD can be difficult, so alternative therapies that help reduce glucose levels are needed. Exogenous ketones provide an alternative method to elevate blood ketone levels without strict dietary requirements. In this study, we tested the changes in blood glucose and ketone (βHB) levels in response to acute, sub-chronic, and chronic administration of various ketogenic compounds in either a post-exercise or rested state. WAG/Rij (WR) rats, a rodent model of human absence epilepsy, GLUT1 deficiency syndrome mice (GLUT1D), and wild type Sprague Dawley rats (SPD) were assessed. Non-pathological animals were also assessed across different age ranges. Experimental groups included KD, standard diet (SD) supplemented with water (Control, C) or with exogenous ketones: 1, 3-butanediol (BD), βHB mineral salt (KS), KS with medium chain triglyceride/MCT (KSMCT), BD acetoacetate diester (KE), KE with MCT (KEMCT), and KE with KS (KEKS). In rested WR rats, the KE, KS, KSMCT groups had lower blood glucose level after 1 h of treatment, and in KE and KSMCT groups after 24 h. After exercise, the KE, KSMCT, KEKS, and KEMCT groups had lowered glucose levels after 1 h, and in the KEKS and KEMCT groups after 7 days, compared to control. In GLUT1D mice without exercise, only KE resulted in significantly lower glucose levels at week 2 and week 6 during a 10 weeks long chronic feeding study. In 4-month and 1-year-old SPD rats in the post-exercise trials, blood glucose was significantly lower in KD and KE, and in KEMCT groups, respectively. After seven days, the KSMCT group had the most significantly reduced blood glucose levels, compared to control. These results indicate that exogenous ketones were efficacious in reducing blood glucose levels within and outside the context of exercise in various rodent models of different ages, with and without pathology.

[1]  D. Ault,et al.  Effects of an Exogenous Ketone Supplement on Five‐Kilometer Running Performance , 2020, Journal of human kinetics.

[2]  K. Clarke,et al.  Why a d-β-hydroxybutyrate monoester? , 2020, Biochemical Society transactions.

[3]  B. Egan,et al.  No Benefit of Ingestion of a Ketone Monoester Supplement on 10-km Running Performance. , 2019, Medicine and science in sports and exercise.

[4]  P. Laursen,et al.  The Effect of 1,3-Butanediol on Cycling Time-Trial Performance. , 2019, International journal of sport nutrition and exercise metabolism.

[5]  P. Hespel,et al.  Ketone ester supplementation blunts overreaching symptoms during endurance training overload , 2019, The Journal of physiology.

[6]  T. Oron,et al.  International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium–Glucose Cotransporter (SGLT) Inhibitors , 2019, Diabetes Care.

[7]  D. Diamond,et al.  Delaying latency to hyperbaric oxygen‐induced CNS oxygen toxicity seizures by combinations of exogenous ketone supplements , 2019, Physiological reports.

[8]  B. Egan,et al.  Intermittent Running and Cognitive Performance after Ketone Ester Ingestion , 2018, Medicine and science in sports and exercise.

[9]  D. Diamond,et al.  Nutritional ketosis delays the onset of isoflurane induced anesthesia , 2018, BMC Anesthesiology.

[10]  Anoop Kumar,et al.  Risks Associated with SGLT2 Inhibitors: An Overview. , 2018, Current drug safety.

[11]  C. Ebbeling,et al.  Management of Type 1 Diabetes With a Very Low–Carbohydrate Diet , 2018, Pediatrics.

[12]  John P. A. Ioannidis,et al.  Effect of Low-Fat vs Low-Carbohydrate Diet on 12-Month Weight Loss in Overweight Adults and the Association With Genotype Pattern or Insulin Secretion: The DIETFITS Randomized Clinical Trial , 2018, JAMA.

[13]  H. Chander,et al.  Exogenous ketone salts do not improve cognitive responses after a high-intensity exercise protocol in healthy college-aged males. , 2018, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.

[14]  Paul T. Williams,et al.  Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 Year: An Open-Label, Non-Randomized, Controlled Study , 2018, Diabetes Therapy.

[15]  B. Egan,et al.  Effect of acute ingestion of β-hydroxybutyrate salts on the response to graded exercise in trained cyclists , 2018, European journal of sport science.

[16]  H. Jelinek,et al.  Hyperglycaemia, oxidative stress and inflammatory markers , 2017, Redox report : communications in free radical research.

[17]  Olivia K. Faull,et al.  On the Metabolism of Exogenous Ketones in Humans , 2017, Front. Physiol..

[18]  J. Hawley,et al.  Ketone Diester Ingestion Impairs Time-Trial Performance in Professional Cyclists , 2017, Front. Physiol..

[19]  J. Little,et al.  Nutritional ketone salts increase fat oxidation but impair high-intensity exercise performance in healthy adult males. , 2017, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.

[20]  Á. Dobolyi,et al.  Adenosine A1 Receptor Antagonism Abolished the Anti-seizure Effects of Exogenous Ketone Supplementation in Wistar Albino Glaxo Rijswijk Rats , 2017, Front. Mol. Neurosci..

[21]  P. Laursen,et al.  Oral β-hydroxybutyrate salt fails to improve 4-minute cycling performance following submaximal exercise , 2017 .

[22]  J. McCarter,et al.  A Novel Intervention Including Individualized Nutritional Recommendations Reduces Hemoglobin A1c Level, Medication Use, and Weight in Type 2 Diabetes , 2017, JMIR diabetes.

[23]  David N. Thibodeaux,et al.  Brain microvasculature defects and Glut1 deficiency syndrome averted by early repletion of the glucose transporter-1 protein , 2017, Nature Communications.

[24]  G. Juhász,et al.  Exogenous Ketone Supplements Reduce Anxiety-Related Behavior in Sprague-Dawley and Wistar Albino Glaxo/Rijswijk Rats , 2016, Front. Mol. Neurosci..

[25]  C. Rae,et al.  β-Hydroxybutyrate in the Brain: One Molecule, Multiple Mechanisms , 2016, Neurochemical Research.

[26]  Daniel L. Smith,et al.  Targeting glucose metabolism for healthy aging , 2016, Nutrition and healthy aging.

[27]  S. Neubauer,et al.  Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes. , 2016, Cell metabolism.

[28]  C. Ari,et al.  Effects of exogenous ketone supplementation on blood ketone, glucose, triglyceride, and lipoprotein levels in Sprague–Dawley rats , 2016, Nutrition & Metabolism.

[29]  J. Preiser,et al.  Time in blood glucose range 70 to 140 mg/dl >80% is strongly associated with increased survival in non-diabetic critically ill adults , 2015, Critical Care.

[30]  L. Wood,et al.  Acute effects of feeding fructose, glucose and sucrose on blood lipid levels and systemic inflammation , 2014, Lipids in Health and Disease.

[31]  A. Constanti,et al.  Early molecular and behavioral response to lipopolysaccharide in the WAG/Rij rat model of absence epilepsy and depressive-like behavior, involves interplay between AMPK, AKT/mTOR pathways and neuroinflammatory cytokine release , 2014, Brain, Behavior, and Immunity.

[32]  K. Yamagata,et al.  Role of Inflammatory Mediators in the Pathogenesis of Epilepsy , 2014, Mediators of inflammation.

[33]  C. Ari,et al.  Metabolic Therapy with Deanna Protocol Supplementation Delays Disease Progression and Extends Survival in Amyotrophic Lateral Sclerosis (ALS) Mouse Model , 2014, PloS one.

[34]  Liang-Jun Yan Pathogenesis of Chronic Hyperglycemia: From Reductive Stress to Oxidative Stress , 2014, Journal of diabetes research.

[35]  M. S. Kirkman,et al.  Type 1 Diabetes Through the Life Span: A Position Statement of the American Diabetes Association , 2014, Diabetes Care.

[36]  T. Seyfried,et al.  Ketone supplementation decreases tumor cell viability and prolongs survival of mice with metastatic cancer , 2014, International journal of cancer.

[37]  G. Juhász,et al.  Lipopolysaccharide induced increase in seizure activity in two animal models of absence epilepsy WAG/Rij and GAERS rats and Long Evans rats , 2014, Brain Research Bulletin.

[38]  P. Veggiotti,et al.  Dietary Treatments and New Therapeutic Perspective in GLUT1 Deficiency Syndrome , 2014, Current Treatment Options in Neurology.

[39]  K. Kimura,et al.  Elevated glucose level adversely affects infarct volume growth and neurological deterioration in non‐diabetic stroke patients, but not diabetic stroke patients , 2014, European journal of neurology.

[40]  M. Dobreanu,et al.  Diabetes and beta cell function: from mechanisms to evaluation and clinical implications , 2013, Biochemia medica.

[41]  A. Paoli,et al.  Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets , 2013, European Journal of Clinical Nutrition.

[42]  Jianping Ye Mechanisms of insulin resistance in obesity , 2013, Frontiers of Medicine.

[43]  Addison K. May,et al.  Stress-Induced Hyperglycemia as a Risk Factor for Surgical-Site Infection in Nondiabetic Orthopedic Trauma Patients Admitted to the Intensive Care Unit , 2013, Journal of orthopaedic trauma.

[44]  T. Vanitallie,et al.  Kinetics, safety and tolerability of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate in healthy adult subjects. , 2012, Regulatory toxicology and pharmacology : RTP.

[45]  K. Clarke,et al.  Oral 28-day and developmental toxicity studies of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate. , 2012, Regulatory toxicology and pharmacology : RTP.

[46]  U. Baxa,et al.  Mitochondrial biogenesis and increased uncoupling protein 1 in brown adipose tissue of mice fed a ketone ester diet , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[47]  C. McClain,et al.  Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury. , 2011, JPEN. Journal of parenteral and enteral nutrition.

[48]  M. Hochuli,et al.  Low to moderate sugar-sweetened beverage consumption impairs glucose and lipid metabolism and promotes inflammation in healthy young men: a randomized controlled trial. , 2011, The American journal of clinical nutrition.

[49]  G. Juhász,et al.  Intracerebroventricularly administered lipopolysaccharide enhances spike–wave discharges in freely moving WAG/Rij rats , 2011, Brain Research Bulletin.

[50]  Ferdinando Giacco,et al.  Oxidative stress and diabetic complications. , 2010, Circulation research.

[51]  P. Mitchell,et al.  Carbohydrate nutrition and inflammatory disease mortality in older adults. , 2010, The American journal of clinical nutrition.

[52]  R. Bracken,et al.  Exercise‐induced hyperglycaemia in the absence of diabetes , 2009, Diabetic medicine : a journal of the British Diabetic Association.

[53]  S Del Prato,et al.  Role of glucotoxicity and lipotoxicity in the pathophysiology of Type 2 diabetes mellitus and emerging treatment strategies , 2009, Diabetic medicine : a journal of the British Diabetic Association.

[54]  S. Kawahito,et al.  Problems associated with glucose toxicity: role of hyperglycemia-induced oxidative stress. , 2009, World journal of gastroenterology.

[55]  R. Choue,et al.  Comparison of time course changes in blood glucose, insulin and lipids between high carbohydrate and high fat meals in healthy young women , 2009, Nutrition research and practice.

[56]  J. Téllez-Zenteno,et al.  Occipital seizures induced by hyperglycemia: A case report and review of literature , 2009, Seizure.

[57]  K. Inaba,et al.  Persistent Hyperglycemia in Severe Traumatic Brain Injury: An Independent Predictor of Outcome , 2009, The American surgeon.

[58]  G. Holmes,et al.  Brain inflammation initiates seizures , 2008, Nature Medicine.

[59]  S. Shapses,et al.  Bone mineral density and content during weight cycling in female rats: effects of dietary amylase-resistant starch , 2008, Nutrition & metabolism.

[60]  J. Klepper Glucose transporter deficiency syndrome (GLUT1DS) and the ketogenic diet , 2008, Epilepsia.

[61]  J. Wheless History of the ketogenic diet , 2008, Epilepsia.

[62]  J. Cross,et al.  The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial , 2008, The Lancet Neurology.

[63]  M. Prins,et al.  Cerebral Metabolic Adaptation and Ketone Metabolism after Brain Injury , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[64]  S. Cheema,et al.  Bio F1B hamster: a unique animal model with reduced lipoprotein lipase activity to investigate nutrient mediated regulation of lipoprotein metabolism , 2007, Nutrition & metabolism.

[65]  I. Nissim,et al.  The ketogenic diet and brain metabolism of amino acids: relationship to the anticonvulsant effect. , 2007, Annual review of nutrition.

[66]  G. Juhász,et al.  Facilitation of spike-wave discharge activity by lipopolysaccharides in Wistar Albino Glaxo/Rijswijk rats , 2006, Neuroscience.

[67]  D. MacGrogan,et al.  A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis , 2006, BMC Neuroscience.

[68]  J. Noebels,et al.  A mouse model for Glut-1 haploinsufficiency. , 2006, Human molecular genetics.

[69]  E. Thiele,et al.  Low-glycemic-index treatment: A liberalized ketogenic diet for treatment of intractable epilepsy , 2005, Neurology.

[70]  L. Niskanen,et al.  Dietary carbohydrate modification enhances insulin secretion in persons with the metabolic syndrome. , 2005, The American journal of clinical nutrition.

[71]  S. Blair,et al.  Physical activity and diabetes prevention. , 2005, Journal of applied physiology.

[72]  H. Roseman Progression from obesity to type 2 diabetes: lipotoxicity, glucotoxicity, and implications for management. , 2005, Journal of managed care pharmacy : JMCP.

[73]  J. Griffith,et al.  Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial. , 2005, JAMA.

[74]  Hong Yang,et al.  Glut‐1 deficiency syndrome: Clinical, genetic, and therapeutic aspects , 2005, Annals of neurology.

[75]  W. Yancy,et al.  A Low-Carbohydrate, Ketogenic Diet versus a Low-Fat Diet To Treat Obesity and Hyperlipidemia , 2004, Annals of Internal Medicine.

[76]  R. Veech The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. , 2004, Prostaglandins, leukotrienes, and essential fatty acids.

[77]  C. Stafstrom,et al.  Hyperglycemia Lowers Seizure Threshold , 2003, Epilepsy currents.

[78]  A. Tagliabue,et al.  The ketogenic diet in children, adolescents and young adults with refractory epilepsy: an Italian multicentric experience , 2002, Epilepsy Research.

[79]  M. Vranic,et al.  Intense exercise has unique effects on both insulin release and its roles in glucoregulation: implications for diabetes. , 2002, Diabetes.

[80]  P. Pyzik,et al.  The ketogenic diet: a 3- to 6-year follow-up of 150 children enrolled prospectively. , 2001, Pediatrics.

[81]  D. Gilbert,et al.  The Ketogenic Diet: Seizure Control Correlates Better With Serum β-Hydroxybutyrate Than With Urine Ketones , 2000, Journal of child neurology.

[82]  H. Gerstein,et al.  Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview , 2000, The Lancet.

[83]  N. Price,et al.  The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation. , 1999, The Biochemical journal.

[84]  R. Klein,et al.  The association of glycemia and cause-specific mortality in a diabetic population. , 1994, Archives of internal medicine.

[85]  J. Halter,et al.  Hyperinsulinemia prevents prolonged hyperglycemia after intense exercise in insulin-dependent diabetic subjects. , 1994, The Journal of clinical endocrinology and metabolism.

[86]  J. Tobin,et al.  The effect of age on insulin response and glucose utilization during four hyperglycemic plateaus , 1993, Experimental Gerontology.

[87]  J. Halter,et al.  Glucose turnover and its regulation during intense exercise and recovery in normal male subjects. , 1992, Clinical and investigative medicine. Medecine clinique et experimentale.

[88]  J. Halter,et al.  Glucoregulatory and hormonal responses to repeated bouts of intense exercise in normal male subjects. , 1991, Journal of applied physiology.

[89]  I. Hirsch,et al.  Insulin and glucagon in prevention of hypoglycemia during exercise in humans. , 1991, The American journal of physiology.

[90]  D. Wasserman,et al.  Glucagon is a primary controller of hepatic glycogenolysis and gluconeogenesis during muscular work. , 1989, The American journal of physiology.

[91]  Lawrence A Leiter,et al.  Hyperglycemia After Intense Exercise in IDDM Subjects During Continuous Subcutaneous Insulin Infusion , 1988, Diabetes Care.

[92]  N. Kalant,et al.  Effect of Age on Glucose Utilization and Responsiveness to Insulin in Forearm Muscle † , 1980, Journal of the American Geriatrics Society.

[93]  J. Biebuyck,et al.  Ketone bodies are selectively used by individual brain regions. , 1979, Science.

[94]  A. Binkiewicz,et al.  An effect of ketones on the concentrations of glucose and of free fatty acids in man independent of the release of insulin. , 1974, The Journal of pediatrics.

[95]  J. Mayer,et al.  Nutrition and athletic performance. , 1959, Journal of the American Medical Association.

[96]  M. Huijberts,et al.  An integrated medical treatment for type-2 diabetes. , 2014, Diabetes & metabolic syndrome.

[97]  H. Brunengraber,et al.  with delays in , 2013 .

[98]  M. Cooper,et al.  Mechanisms of diabetic complications. , 2013, Physiological reviews.

[99]  Eric L. Johnson Glycemic variability in type 2 diabetes mellitus: oxidative stress and macrovascular complications. , 2012, Advances in experimental medicine and biology.

[100]  E. Kossoff,et al.  Ketosis and the ketogenic diet, 2010: advances in treating epilepsy and other disorders. , 2010, Advances in pediatrics.

[101]  R. Robertson,et al.  Glucolipotoxicity : Fuel Excess and-Cell Dysfunction , 2008 .

[102]  R. Gougeon,et al.  The Impact of Low-carbohydrate Diets on Glycemic Control and Weight Management in Patients With Type 2 Diabetes , 2006 .

[103]  Nutrition & Metabolism BioMed Central Review Targeting energy metabolism in brain cancer: review and , 2005 .

[104]  A. Girija,et al.  Seizures in hyperglycemic patients. , 2001, The Journal of the Association of Physicians of India.

[105]  G. Reaven,et al.  Plasma glucose, insulin and lipid responses to high-carbohydrate low-fat diets in normal humans. , 1983, Metabolism: clinical and experimental.